entertainment -WSS

entertainment

author：hotspot 2025-10-01 10:36:35 - browse：9

A person reaching for a bottle of lipitor. -- first opinion coverage from STAT — John Moore/Getty Images

The antibiotics crisis is a silent pandemic that threatens to knock modern society back into the medieval age of therapeutic leaches and serum therapy. A world where an accidental scratch in the rose garden can kill.

Why is the supply of new antibiotics so thin, and growing thinner? A high-profile Wall Street Journal article recently highlighted what everyone knows: There is huge need but no market demand.

There are many interrelated causes. Doctors prefer to keep novel antibiotics in reserve, as a last-resort option, limiting sales volumes. Insurance companies like novel antibiotics that prevent costly ICU stays, but they’re used to the cheap price of older generics and balk at any price that allows recoupment of the full cost of development. Low prices and small volumes are a great recipe for insolvency as Achaogen’s experience showed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Where does female orgasm come from? Scientists think they know

focus

WSS

Severe heat forecast: Where scorching temperatures will persist over the next week

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

New oral drug delivery patch is modeled after octopus tentacles

2023 Nobel Prize in Medicine goes to Karikó and Weissman

leisure time

entertainment

Wikipedia

Sports medicine is finally prioritizing gender equality

Flu, Covid vaccination rates decline, new survey data show

Duchenne breakthrough therapy leaves behind pioneering families

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Medicare proposal to cover medical devices draws a mixed reaction

How to protect coverage of PrEP

Supreme Court strikes down use of affirmative action

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

What does generative AI mean for health care? We asked experts

The Karikó problem: Lessons for funding basic research

Wikipedia

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

The United States is paying nearly triple for new Covid vaccines

IVG is promising — but it won’t replace IVF quite yet

RSV injection headlines need to be accurate for good uptake

FDA approves first blood sugar monitor without finger pricks

European officials brace for rough respiratory virus season

leisure time

explore

focus

focus